Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system.
| Authors | |
| Keywords | |
| Abstract | The ability to artificially control transcription is essential both to the study of gene function and to the construction of synthetic gene networks with desired properties. Cas9 is an RNA-guided double-stranded DNA nuclease that participates in the CRISPR-Cas immune defense against prokaryotic viruses. We describe the use of a Cas9 nuclease mutant that retains DNA-binding activity and can be engineered as a programmable transcription repressor by preventing the binding of the RNA polymerase (RNAP) to promoter sequences or as a transcription terminator by blocking the running RNAP. In addition, a fusion between the omega subunit of the RNAP and a Cas9 nuclease mutant directed to bind upstream promoter regions can achieve programmable transcription activation. The simple and efficient modulation of gene expression achieved by this technology is a useful asset for the study of gene networks and for the development of synthetic biology and biotechnological applications. |
| Year of Publication | 2013
|
| Journal | Nucleic Acids Res
|
| Volume | 41
|
| Issue | 15
|
| Pages | 7429-37
|
| Date Published | 2013 Aug
|
| ISSN | 1362-4962
|
| URL | |
| DOI | 10.1093/nar/gkt520
|
| PubMed ID | 23761437
|
| PubMed Central ID | PMC3753641
|
| Links | |
| Grant list | DP2 AI104556 / AI / NIAID NIH HHS / United States
R01 GM044025 / GM / NIGMS NIH HHS / United States
1DP2AI104556-01 / AI / NIAID NIH HHS / United States
DP1MH100706 / DP / NCCDPHP CDC HHS / United States
|